Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

Journal of Molecular and Cellular Cardiology
Buddhadeb DawnR Bolli

Abstract

The role of tumor necrosis factor (TNF)-alpha in myocardial ischemia/reperfusion injury remains controversial. We used homozygous TNF-alpha null mice (TNF-alpha(-/-)) to determine whether TNF-alpha modulates myocardial ischemia/reperfusion injury. Mice were subjected to a 30-min coronary occlusion followed by 24 h of reperfusion. When wild-type mice were preconditioned with six cycles of 4-min coronary occlusion/4-min reperfusion 24 h before the 30-min occlusion, infarct size was reduced from 58.6 +/- 1.9% of the risk region to 19.3 +/- 3.6%, indicating a late preconditioning (PC) effect. In non-preconditioned TNF-alpha(-/-) mice, infarct size was similar to that observed in wild-type mice (55.5 +/- 3.7%). However, in TNF-alpha(-/-) mice preconditioned with six occlusion/reperfusion cycles 24 h earlier, infarct size was not reduced (55.2 +/- 5.7%), indicating that the late PC protection against infarction was completely abolished. While minimal TNF-alpha immunoreactivity was detected in sham-operated hearts, extensive TNF-alpha expression was noted in the cytoplasm of cardiomyocytes in the ischemic/reperfused region 30 min after the PC ischemia. At 30 min after PC, wild-type mice exhibited increased DNA-binding activity of nucl...Continue Reading

Citations

Feb 7, 2014·Cardiovascular Research·Shuxia JiangFrancis J Miller
Nov 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ian MoenchHerbert Weissbach
May 9, 2012·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Eva S KehmeierTienush Rassaf
Feb 10, 2011·European Heart Journal·Sandrine Lecour, Richard W James
Jun 24, 2010·Heart Failure Reviews·Petra KleinbongardGerd Heusch
Sep 4, 2009·Apoptosis : an International Journal on Programmed Cell Death·S KaloustianG Rousseau
May 25, 2010·Cardiovascular Drugs and Therapy·Derek J Hausenloy, Derek M Yellon
Oct 6, 2007·Expert Opinion on Biological Therapy·Ming Zhang, Michael C Carroll
Jul 14, 2005·Fundamental & Clinical Pharmacology·M Joyeux-FaureC Ribuot
Aug 1, 2006·Molecular Immunology·Ming Zhang, Michael C Carroll
May 28, 2005·Circulation Research·Roberta Gottlieb
Jun 19, 2010·Journal of Cardiovascular Translational Research·Bingbing Jiang, Ronglih Liao
Sep 27, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jingang ZhengJay M Edelberg
Sep 18, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Ting C ZhaoTai L Guo
Jan 25, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Chunlian ZhangCam Patterson
Apr 19, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Ming ZhangNaranjan S Dhalla
Mar 12, 2011·Journal of Applied Physiology·Chad R FrasierDavid A Brown
Jul 6, 2020·Nature Reviews. Cardiology·Gerd Heusch
Mar 20, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Yukio SaitoKiyotaka Kugiyama
Jun 19, 2014·Journal of Cardiovascular Pharmacology and Therapeutics·Tamar Ben-MordechaiJonathan Leor
May 27, 2020·Mediators of Inflammation·Naren Bao, Bing Tang
Mar 27, 2021·Basic Research in Cardiology·Luca LiberaleFabrizio Montecucco
Oct 1, 2008·Journal of Molecular and Cellular Cardiology·Michael P FlahertyBuddhadeb Dawn
Oct 15, 2008·Journal of Molecular and Cellular Cardiology·Rainer Schulz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis